Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
JUN mRNA encodes the c-Jun protein, a critical component of the Activator Protein-1 (AP-1) transcription factor complex. This complex regulates the expression of genes involved in essential cellular processes such as proliferation, differentiation, and apoptosis in response to growth factors, cytokines, and environmental stress (NCBI Gene ID: 3725). In many pathological states, particularly various forms of cancer and inflammatory diseases, JUN is overexpressed, driving uncontrolled cell growth, survival, and tissue remodeling (UniProt P05412). Targeting the JUN mRNA directly using nucleic acid-based therapeutics, such as DNAzymes or siRNAs, allows for the specific knockdown of c-Jun protein production. For example, the DNAzyme DZ13 has been designed to specifically target and cleave JUN mRNA, showing promise in preclinical models and early clinical trials for treating solid tumors and skin conditions like squamous cell carcinoma (PubMed: 23319574). However, therapeutic challenges remain regarding the efficient delivery of these agents to target tissues and the potential for off-target effects given the broad biological role of the AP-1 complex in normal cell function.
mRNA cleavage and degradation via DNAzymes or RNA interference, and translational inhibition via antisense oligonucleotides.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Jun proto-oncogene, AP-1 transcription factor subunit mRNA (JUN) (JUN).